BeriCos® AZA: Azelaic Acid Cream Formulation and Application in Modern Skin Care
Introduction
Azelaic acid (BeriCos® AZA CAS: 123-99-9 ) is a saturated dicarboxylic acid that has become an important active ingredient in dermatological and cosmetic formulations. It is widely investigated and used for applications associated with acne-prone skin, uneven skin tone, hyperpigmentation, and inflammatory skin conditions. Commercial topical products commonly use azelaic acid at concentrations ranging from approximately 5% to 20%, with cream and gel systems among the most established dosage forms.
BeriCos® AZA Azelaic acid provides a formulation opportunity for incorporating azelaic acid into modern topical cream systems. From a formulation perspective, successful development requires more than simply dispersing the active ingredient into an emulsion. Azelaic acid has relatively low water solubility and a high melting point, creating challenges related to solubilization, particle size, physical stability, skin feel, and uniform distribution within the finished product.
This article discusses the key formulation considerations, application possibilities, and development principles for a BeriCos® AZA -based Azelaic acid cream.
1. Why Azelaic acid Is an Attractive Cosmetic Active
Azelaic acid has several properties that make it attractive for multifunctional skin-care products. Its biological activities include antimicrobial, anti-inflammatory, and antimelanogenic effects. Consequently, topical AZA has been studied for acne vulgaris, rosacea, melasma, and post-inflammatory hyperpigmentation.
For cosmetic applications, these properties can translate into product concepts designed to support:
Acne-prone and blemish-prone skin
Uneven skin tone
The appearance of post-inflammatory marks
Dull or rough-looking skin
Redness-prone skin
Overall skin texture and complexion appearance
The performance of azelaic acid is strongly influenced by the formulation vehicle. Research indicates that formulation strategies can be used to improve solubilization, skin deposition, delivery, stability, and tolerability.
2. The Main Formulation Challenge: Azelaic acid Solubility
One of the most important considerations when developing an AZA cream is its limited aqueous solubility. Azelaic acid has a reported aqueous solubility of approximately 2.4 mg/mL at 25 °C and a melting point around 106.5 °C. These characteristics make conventional incorporation into an aqueous cream challenging.
Depending on the target formulation, azelaic acid may therefore be incorporated as:
A finely dispersed solid phase
A partially or substantially solubilized active
A combination of dissolved and dispersed AZA
An advanced delivery system designed to improve cutaneous deposition
The choice depends on the desired concentration, sensory profile, manufacturing process, regulatory positioning, and stability requirements.
For a commercial cream, control of AZA particle size and dispersion is particularly important. Poor dispersion can lead to sedimentation, grittiness, non-uniform dosing, poor aesthetics, and reduced consumer acceptance.
3. Conceptual BeriCos® AZA Cream Formulation
A typical oil-in-water cream containing BeriCos® AZA Azelaic acid can be designed around several functional components:
A useful development target is a cream that combines uniform AZA Azelaic acid distribution, acceptable viscosity, smooth application, low grittiness, good stability, and a pleasant after-feel.
4. Manufacturing Approach
A robust manufacturing process can generally be divided into several stages.
Phase A – Aqueous Phase
Water-soluble ingredients such as humectants, chelating agents, and selected water-soluble polymers can be incorporated into the aqueous phase.
Phase B – Oil Phase
Oil-soluble ingredients, emollients, emulsifiers, and consistency agents are combined and processed according to the requirements of the selected emulsification system.
Phase C – AZA Incorporation
The incorporation strategy for BeriCos® AZA should follow the supplier's technical recommendations.
Particular attention should be paid to:
AZA particle size
Dispersion quality
Addition temperature
Mixing intensity
Order of addition
Homogenization conditions
Potential interactions with emulsifiers and polymers
If AZA is incorporated predominantly as a dispersed solid, sufficient shear and appropriate rheology are important for maintaining a homogeneous system.
Emulsification
The aqueous and oil phases are combined under controlled mixing conditions to produce the desired emulsion structure.
After emulsification, the batch is cooled under controlled agitation. Ingredients that are temperature-sensitive should be incorporated during the appropriate cooling stage.
The final product should then be adjusted to the target pH and viscosity before filling.
5. pH Considerations
pH is an important development parameter for an azelaic acid cream because it can influence active-ingredient behavior, preservative performance, polymer viscosity, skin compatibility, and overall formulation stability.
The optimum pH should therefore not be selected solely on the basis of the active ingredient. It should be established experimentally by evaluating:
AZA physical stability
Emulsion stability
Preservative efficacy
Polymer compatibility
Skin compatibility
Long-term storage stability
A controlled pH is particularly important when combining AZA with other functional ingredients.
6. Application Opportunities
BeriCos® AZA Azelaic acid can be considered for several topical skin-care concepts, subject to the final concentration, formulation, regulatory status, and substantiation of the finished product.
Acne-Prone Skin
Azelaic acid has established dermatological relevance in acne management. Its antimicrobial and anti-inflammatory properties make AZA-containing topical formulations particularly interesting for products targeting blemish-prone skin.
Uneven Skin Tone and Hyperpigmentation
Azelaic acid also has antimelanogenic activity and has been investigated for melasma and post-inflammatory hyperpigmentation. This makes it suitable for cosmetic concepts focused on improving the appearance of uneven pigmentation and promoting a more uniform-looking complexion.
Redness-Prone Skin
The anti-inflammatory properties of AZA have contributed to its use in formulations for inflammatory skin conditions, including rosacea. However, cosmetic claims should be carefully distinguished from therapeutic claims and supported by appropriate evidence.
7. Formulation Performance and Stability Testing
A BeriCos® AZA Azelaic acid cream should undergo comprehensive testing before commercialization.
Important development tests include:
Physical stability
Appearance
Color and odor
Phase separation
Sedimentation
Particle/crystal formation
Viscosity
pH
Chemical stability
AZA assay
Degradation products, where relevant
Compatibility with other active ingredients
Microbiological quality
Total microbial count
Specified microorganisms
Preservative efficacy/challenge testing, where applicable
Packaging compatibility
Container interaction
Changes in viscosity or appearance
Active-content stability
Leakage and dispensing performance
Accelerated and long-term stability studies should be conducted using the intended commercial packaging.
8. Sensory Profile
An important advantage of cream formulation is the ability to balance active delivery with consumer comfort.
For an BeriCos® AZA Azelaic acid cream, the desired sensory characteristics may include:
Smooth and homogeneous texture
Easy spreadability
Minimal tackiness
Low visible residue
Non-gritty application
Rapid or comfortable absorption
Pleasant after-feel
Because BeriCos® AZA Azelaic acid can be challenging to formulate at relatively high concentrations, sensory optimization should be treated as an integral part of formulation development rather than as a final-stage adjustment.
9. Advanced Formulation Strategies
Conventional creams remain important, but newer delivery technologies are being investigated to address the solubility and permeability limitations of azelaic acid.
Research has explored liposomes, niosomes, ethosomes, microemulsions, nanostructured lipid carriers, nanosponges, polymeric systems, and deep eutectic solvent-based approaches. These technologies aim to increase Azelaic acid AZA solubilization, improve skin deposition, enhance stability, or reduce irritation.
For BeriCos® AZA Azelaic acid , such approaches could provide opportunities for developing differentiated products where conventional cream technology does not provide the desired performance.
10. Conclusion
BeriCos® AZA Azelaic acid offers an interesting platform for the development of modern azelaic-acid-based topical creams. The key to successful formulation is controlling the interaction between the active ingredient and the cream vehicle.
Because azelaic acid has limited aqueous solubility and presents formulation challenges, careful selection of the dispersion/solubilization approach, emulsifier system, rheology modifiers, pH, processing conditions, and packaging is essential.
A well-designed BeriCos® AZA Azelaic acid cream can combine the established multifunctionality of azelaic acid with the consumer benefits of a cosmetically elegant topical formulation. Future formulation development may also explore advanced delivery technologies to improve active distribution, skin deposition, stability, and tolerability.
Ultimately, the most successful BeriCos® AZA Azelaic acid formulation should be evaluated not only for active-ingredient content but also for stability, homogeneity, sensory performance, skin compatibility, and demonstrated finished-product efficacy.
If you need more technical documents and trial samples, feel free to contact us.
Elena@zhberi.com +8619500796925
Azelaic acid manufacturer - Beri Pharma
Comments
Post a Comment